Sosei Heptares

Last update: September 3, 2020

United Kingdom (UK) Its 13 main executives

Recent executive movements at Sosei Heptares

Hironoshin Nomura has joined the company as Senior Vice President, Investor Relations and Corporate Strategy  (news posted on September 3 2020).
Shinichi Tamura who was Chief Executive Officer, becomes Chairman of the Board  (news posted on March 25 2020).
Malcolm Weir, who was Executive Vice President, Research and Early Development, is promoted to Executive Chairman  (news posted on March 25 2020).

Click here to view some more movements at Sosei Heptares

Create an alert
to follow the executive moves at Sosei Heptares.

Most searched biographies at Sosei Heptares

Click on an executive to view his biography >

Latest M&A news in Pharmaceuticals.

Bristol-Myers Squibb has announced the acquisition of MyoKardia (posted on Oct 6, 2020).
DelMar Pharmaceuticals has announced the acquisition of Kintara Therapeutics (posted on Aug 19, 2020).
Elanco has acquired Bayer Animal Health (posted on Aug 5, 2020).

Other contacts in the Pharmaceuticals industry

Learn more about the Pharmaceuticals industry >

Latest news about Sosei Heptares

Sosei Heptares on Wikipedia, Google News & Yahoo Finance

Sosei Heptares on LinkedIn, Twitter & YouTube

Sosei Heptares has 2,016 competitors including Sun Pharma (India), Johnson & Johnson (United States (USA)) and Roche (Switzerland). Sosei Heptares is owned by Sosei.

The most constantly updated executive directory.



Learn about your clients' org charts. Understand their industries and their competitors.



View the executives' biographies. Contact the executives through our email platform.



Select key words to follow your clients. Receive alerts when executive movements happen.


Track your clients

File your clients in folders. Add private notes. Download our data in Excel on your PC.